Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 19 de 19
Filtrar
1.
China Journal of Chinese Materia Medica ; (24): 2732-2739, 2018.
Artículo en Chino | WPRIM | ID: wpr-687392

RESUMEN

The chemical constituents from the ethanol extract of Clerodendrum japonicum were isolated by a combination of various chromatographic techniques including column chromatography over silica gel, sephadex LH-20, ODS and reversed phase HPLC. Sixteen compounds with a pair of epimers were elucidated through the application of physicochemical properties with modern spectral analysis technology as 7α-hydroxy syringaresinol (1), (-)-syringaresinol (2), (-)-medioresinol (3), 2″,3″--acetylmartyonside (4), 2″--acetyl-martyonside (5), martinoside (6), monoacetyl martinoside (7),cytochalasin O (8), 9-epi-blumenol B (9), (6R, 9S) and (6R,9)-9-hydroxy-4-megastigmen-3-one (10a,10b), (6R,9S)-3-oxo-α-ionol (11), (-)-dehydrovomifoliol (12),megastigm-5-en-3,9-diol (13), (3R,6E,10S)-2,6,10-trimethyl-3-hydroxydodeca-6,11-diene-2,10-diol (14), (2)-butylitaconic acid (15), 3-(3&-hydroxybutyl)-2,4,4-trimethylcyclohexa-2,5-dienone (16), (-)-loliolide (17), of which compound 1 and 15 are new natural product, the other compounds were isolated for the first time from Clerodendrum japonicum except for compounds 4, 6 and 7.

2.
National Journal of Andrology ; (12): 429-433, 2013.
Artículo en Chino | WPRIM | ID: wpr-350885

RESUMEN

<p><b>OBJECTIVE</b>To investigate father-to-infant transmission of hepatitis B virus (HBV) by detecting HBV mRNA in the IVF embryos with paternal HBV infection.</p><p><b>METHODS</b>We collected 18 discarded IVF embryos (9 cases) with paternal chronic HBV infection, and detected HBV mRNA in the embryos by single-cell RT-PCR.</p><p><b>RESULTS</b>HBV mRNA positive signals were found in 1 of the 18 embryos with paternal serum HBV positive markers (5.6%), but no specific HBV mRNA signals were observed in the 84 embryos of the negative control group. Follow-up visits revealed no significant difference between the experimental and negative control groups either in the rate of clinical pregnancy (P > 0.05) or in that of early abortion (P > 0.05). The IVF embryo with paternal HBV mRNA positive signals was successfully implanted, but early abortion occurred. HBV infection was not transmitted to progeny in either of the two groups.</p><p><b>CONCLUSION</b>The positive results of HBV mRNA indicate that HBV can get into early-cleavage embryos through sperm and replicate there, which may be the main channel of father-to-infant transmission. HBV may interfere with the development of embryos, and even result in abortion and other adverse outcomes.</p>


Asunto(s)
Adulto , Femenino , Humanos , Masculino , Embarazo , Adulto Joven , Embrión de Mamíferos , Virología , Padre , Fertilización In Vitro , Hepatitis B , Virología , Virus de la Hepatitis B , Genética , Transmisión Vertical de Enfermedad Infecciosa , ARN Mensajero , Genética , ARN Viral , Genética
3.
Chinese Journal of Hepatology ; (12): 511-516, 2011.
Artículo en Chino | WPRIM | ID: wpr-330708

RESUMEN

<p><b>OBJECTIVE</b>To study the expressions of cyclooxygenase-2 (COX-2) and Peroxisome proliferator-activated receptor gamma (PPARg) in liver of patients with hepatitis B virus (HBV) related acute-on-chronic liver failure (ACLF) and their correlation with clinical parameters.</p><p><b>METHODS</b>35 patients with ACLF, 35 patients with HBV related chronic liver failure (CLF), 27 patients with chronic hepatitis B(CHB) and 15 normal control were enrolled to study the expressions of COX-2 and PPARg in the liver tissues by immunohistochemical staining, and to analyze the correlation of the COX-2 and PPARg levels in liver tissues with clinical parameters.</p><p><b>RESULTS</b>COX-2 was distinctly expressed in the cytoplasm of the hepatocytes, but PPARg was mostly expressed in the nuclei of the hepatocytes and also could be seen in the cytoplasm. The expressions of COX-2 in the liver of ACLF, CLF and CHB groups increased significantly as compared with NC group (z = -5.18, -4.50, -5.32, P is less than 0.01). The levels of COX-2 in ACLF livers also increased evidently as compared with CLF groups (z = -1.98, P is less than 0.05). The expression levels of PPARg in ACLF liver tissues were much higher than the other three groups, and statistical significances existed between ACLF group and the other two groups (CLF, NC groups) (z = -2.62, -4.28, P is less than 0.01). In ACLF group, the expression of COX-2 correlated with MELD score (r = 0.337, P is less than 0.05) and the expression of PPARg correlated with HBV DNA load (r = 0.348, P is less than 0.05). Clinical data showed that the levels of AST, TBil, CHOL, PT, INR, FIB and MELD score in ACLF group were significantly different from that in CLF, CHB and NC groups.</p><p><b>CONCLUSIONS</b>COX-2 expressed in liver may be a marker to reflect the degree of inflammation and injury of liver tissue. The PPARg expression of liver could be increased during chronic HBV infection and may be a protective mechanism against liver injury.</p>


Asunto(s)
Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Adulto Joven , Estudios de Casos y Controles , Ciclooxigenasa 2 , Metabolismo , Enfermedad Hepática en Estado Terminal , Metabolismo , Virología , Virus de la Hepatitis B , Hígado , Metabolismo , Fallo Hepático Agudo , Metabolismo , Virología , PPAR gamma , Metabolismo
4.
Journal of Southern Medical University ; (12): 1955-1959, 2009.
Artículo en Chino | WPRIM | ID: wpr-336047

RESUMEN

<p><b>OBJECTIVE</b>To construct a yeast expression vector of hepatitis B virus (HBV) PreS1 gene using the Sos-recruitment system (SRS), and evaluate the effect of the expression product on the growth of the yeast cells and activation of the reporter gene.</p><p><b>METHODS</b>The coding sequence of HBV preS1 was amplified by PCR and cloned into the yeast expression plasmid pSos. The recombinant bait plasmid pSos- PreS1 was verified by sequencing before transformation into competent yeast cells. The effects of the expression product on the yeast cell growth and activation of the reporter gene were evaluated.</p><p><b>RESULTS</b>The yeast expression vector of HBV PreS1 gene was constructed successfully. The recombinant bait plasmid showed no toxic effect on yeast cdc25H cells without a self-activation of the reporter gene.</p><p><b>CONCLUSION</b>The SRS can be used to study the proteins interacting with HBV PreS1 protein and provides a means for obtaining insight into the pathogenic mechanism of HBV.</p>


Asunto(s)
Humanos , Clonación Molecular , Vectores Genéticos , Genética , Antígenos de Superficie de la Hepatitis B , Genética , Plásmidos , Genética , Precursores de Proteínas , Genética , Receptores Virales , Metabolismo , Proteínas Recombinantes de Fusión , Genética , Técnicas del Sistema de Dos Híbridos , Levaduras , Genética , Metabolismo
5.
Chinese Journal of Epidemiology ; (12): 797-801, 2009.
Artículo en Chino | WPRIM | ID: wpr-261277

RESUMEN

Objectlve To evaluate the intervention effects for road traffic accident prevention among middle school students through understanding their knowledge,attitude and practice (KAP) on road safety.Methods Students in Grade 1 and Grade 2 from 7 junior and senior middle schools in Ji’nan city were selected as intervention group and students from a middle school in Hefei city served as control group.Education was provided to the intervention group and all the middle school students in Ji’nan city.Changes of KAP on road safety were measured for both groups during the follow—up period,and comparison on KAP for the two groups Was carried staffstically. Results The mean scores of road safety knowledge for intervention group improved significantly during the follow-up period(from 0.9-3.8),while these indices did not change much in the control group(from 0—0.2).Negative attitude on road safety was found in both groups,but less in the intervention group.More students started to admit that middle school students themselves should be responsible for most of the RTAs.Per week frequency of violating traffic rules did not improve,however during the follow-up period on both groups as still 75% to 80% of the students violating the traffic rules less than 2 times per week.Although three kinds and one kind of iraffic rules violation seemed to have improved in the intervention group and in the control group,there were still two and three other kinds tumed worse in the intervention and in the control group,respectively.Conclusion Program on road safety education significantly improved the relative knowledge for middle school student and it exerted positive effeets in road safety attitude to some extent.However,no significant effect was found in the improvement on their behavior.Education on road safety should be carried out in the early stage of childhood with newer and more effective intervention approaches.

6.
Chinese Journal of Epidemiology ; (12): 999-1002, 2008.
Artículo en Chino | WPRIM | ID: wpr-298338

RESUMEN

Objective To investigate the predietors of road traffic accidents(RTAs)in middle school students.a ease-control study WaS designed to seek new clues for prevention and control on RTAs in this population.Methods Cases were 116 students who experienced RTAs from 2005/01/01 to 2005/12/31.116 students were.served as controls who were from the same clams of the cases and matched by age and sex.Information on personal behavior,family conditions,and knowledge,attitude,practice(KAB)on road traffic of these children were collected and compared.Conditionallogistic regressions were conducted to analyze the relationship between these factors and RTAs.Results Compared to the controls.the cases showed more negative attitude and risk-taking-behaviors especially in riding bicycle.However,knowledge on road safety showed less significant differences between eaSe and control groups.The negative attitude and risk-taking-behaviors were independent risk factors for RTAs by logistic regression.In addition.distance from home to school that longer than 1000 m seemed a risk factors for RTAs.while high education levels among mothers WaS a protective factor.Conclusion Road safety attitude and behavior.distance from home to school were the main influenee factors for RTAs among middle school students.It seemed more important in improving the attitude and behavior on road safety than to enhance the knowledge for prevention and eontrol of RTAs among middle school students.

7.
Chinese Journal of Hepatology ; (12): 481-484, 2007.
Artículo en Chino | WPRIM | ID: wpr-230557

RESUMEN

<p><b>OBJECTIVE</b>The aim of this paper was to investigate the factors associated with viral response and HBeAg seroconversion and the relationship between them at different stages of interferon treatment in HBeAg-positive chronic hepatitis B patients.</p><p><b>METHODS</b>PEG-IFN alfa-2a was injected subcutaneously in doses of 180 microg once a week for 48 weeks to HBeAg-positive chronic hepatitis B patients, and the patients were followed for another 24 weeks after the treatment. The serum HBV DNA load was measured by real-time quantitative PCR assay. Microparticle enzyme immunoassay analysis (MEIA) was then carried out by an automatic enzyme immunoassay analysis instrument to measure HBeAg and anti-HBe. Virological response and HBeAg seroconversion rates, and the factors associated with them were analyzed.</p><p><b>RESULTS</b>The differences in ALT baselines between viral responding and non-responding groups were significant at treatment time and at the end of the follow-up period. These differences were also significant in patients with HBeAg seroconversion at 12 weeks and at the end of the follow-up period compared with the non-conversion group. No significant difference of HBV DNA baseline was observed between the HBeAg seroconversion and non-conversion group. At 12, 24 and 48 weeks, in patients with viral response during the treatment, their HBeAg seroconversion rates were 43.8%, 21.4% and 18.9% respectively; their respective HBeAg seroconversion rates remaining at 72 weeks were 42.9%, 33.3% and 27.6%. HBeAg seroconversion was related to HBV DNA negativity at 48 weeks treatment in the multivariate analysis (OR=2.15, 95.0% CI=1.744-2.664, P less than 0.01).</p><p><b>CONCLUSIONS</b>Viral response and early and sustained HBeAg seroconversion were associated with pretreatment ALT levels. HBeAg seroconversion was related to viral response during IFN treatment, but not to the baseline HBV DNA load.</p>


Asunto(s)
Adolescente , Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Adulto Joven , Antivirales , Usos Terapéuticos , Antígenos e de la Hepatitis B , Sangre , Virus de la Hepatitis B , Hepatitis B Crónica , Sangre , Quimioterapia , Virología , Interferón-alfa , Usos Terapéuticos , Polietilenglicoles , Usos Terapéuticos , Proteínas Recombinantes
8.
Journal of Southern Medical University ; (12): 1809-1813, 2007.
Artículo en Chino | WPRIM | ID: wpr-281535

RESUMEN

<p><b>OBJECTIVE</b>To analyze the interaction of hepatitis C virus (HCV) core protein with HCBP1 and observe the expression and cellular localization of HCBP1.</p><p><b>METHODS</b>The cDNA fragments encoding HCV core protein and HCBP1 were amplified by PCR and subsequently cloned into pGEM T vector, respectively. After sequence verification, the two recombined vectors were respectively subcloned into two hybrid plasmids, pM and pVP16. pM-core, pVP16- HCBP1 and the reporter vector pG5CAT were co-transfected into COS-7 cells, and the interaction between HCV core protein and HCBP1 was assayed by detecting CAT gene expression after 48 h. The expression and subcellular localization of the fusion protein in the transfected COS-7 cells were analyzed by Western blotting and fluorescence microscopy, respectively.</p><p><b>RESULTS</b>CAT-ELISA showed that the absorbance of the co-transfection group was significantly higher than that o f the negative control groups but lower than that of the positive control group. Western blotting confirmed the expression of fusion protein in the transfected COS-7 cells. Fluorescence microscopy showed that the fusion protein was distributed mainly in the cytoplasm, and in contrast, diffuse EGFP expression was detected in COS-7 cells transfected with the empty vector.</p><p><b>CONCLUSION</b>Mammalian two-hybrid assay confirms the capacity of HCBP1 to bind HCV core protein, and the expression vector for HCBP1-EGFP fusion gene has been constructed successfully and expressed in COS-7 cells.</p>


Asunto(s)
Animales , Secuencia de Bases , Células COS , Chlorocebus aethiops , Vectores Genéticos , Datos de Secuencia Molecular , Plásmidos , Unión Proteica , Receptores Virales , Metabolismo , Proteínas Recombinantes de Fusión , Metabolismo , Transfección , Proteínas del Núcleo Viral , Metabolismo
9.
Chinese Journal of Hepatology ; (12): 3-6, 2006.
Artículo en Chino | WPRIM | ID: wpr-245767

RESUMEN

<p><b>OBJECTIVE</b>To evaluate the efficacy and investigate the influencing factors of the interferon (IFN) retreatment for patients with chronic hepatitis C relapsed after a previous IFN treatment.</p><p><b>METHODS</b>A retrospective study was designed to analyze the retreatment with IFN of 60 relapsed chronic hepatitis C patients. All patients were from a randomized, opened and multi-center clinical trial about the efficacy and security of PEG-IFNalpha-2a compared to CIFNalpha-2a in the treatment of chronic hepatitis C in China. There were 35 patients treated with PEG-IFNalpha-2a and 25 with CIFNalpha-2a. The main parameter to evaluate the efficacy was sustained viral response (SVR) rate. The influence of viral concentration in serum, genotype and drug categories on the responses to IFN were analyzed.</p><p><b>RESULTS</b>For all the patients, the end of treatment virus response (ETVR) and SVR rates were 55.00% and 35.00% respectively. ETVR rate of PEG-IFNalpha-2a was significantly higher than that of CIFNalpha-2a (74.29% and 28.00% respectively, P < 0.01). SVR rate of PEG-IFNalpha-2a was also markedly higher than that of CIFNalpha-2a (45.71% and 20.00% respectively, P < 0.05). However, there was no significant difference between the high and low viral load groups. Among the patients with genotype 1, ETVR and SVR rates of PEG-IFNalpha-2a (75.00%, 45.83%) were significantly higher than those of CIFNalpha-2a (22.22%, 11.11%), (P < 0.01, P < 0.05 respectively), but in patients with genotype non-1, there were no such differences between the two groups.</p><p><b>CONCLUSION</b>Some relapsed patients were not responsive to the IFN retreatment. The efficacy of PEG-IFNalpha-2a was superior to CIFNalpha-2a. The conventional IFN was not suggested to be used in the relapsed cases with genotype 1. The viral load was not associated with the efficacy of IFN retreatment.</p>


Asunto(s)
Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Antivirales , Usos Terapéuticos , Hepatitis C Crónica , Terapéutica , Interferón-alfa , Usos Terapéuticos , Interferón beta , Interferones , Usos Terapéuticos , Polietilenglicoles , Usos Terapéuticos , Proteínas Recombinantes , Recurrencia , Estudios Retrospectivos
10.
Chinese Journal of Hepatology ; (12): 264-267, 2006.
Artículo en Chino | WPRIM | ID: wpr-245684

RESUMEN

<p><b>OBJECTIVE</b>To study the role of the HBV-infected mothers' PBMC in intrauterine transmission of HBV to their fetuses.</p><p><b>METHODS</b>Thirty pregnant women with serum HBV DNA negative and PBMC HBV DNA positive and their newborns were used as the study group. Ten pregnant women with serum HBV negative and their infants served as the control group. HBV DNA in serum and in PBMC was detected using nested polymerase chain reaction (n-PCR). The mothers' PBMC in newborns' peripheral blood was examined using heminested-PCR.</p><p><b>RESULTS</b>Four newborns were serum HBV DNA positive and 8 newborns were HBV DNA positive in PBMC in the study group. Among them, 2 newborns were HBV DNA positive in both serum and PBMC, 6 cases were positive in PBMC only, and 2 cases were positive in serum only. Five mothers had the GSTM1 gene; and it was not detected in 3 newborns. Among the 8 newborns with HBV DNA positive in PBMC, 3 did not have the GSTM1 gene, at the same time their mothers possessed the GSTM1 gene. Mothers' PBMC were detected in all of these three newborns' peripheral blood. HBV DNA in serum and in PBMC of the control group infants were all negative.</p><p><b>CONCLUSION</b>HBV-infected PBMC of the mother may serve as a vector in HBV intrauterine infection.</p>


Asunto(s)
Adulto , Femenino , Humanos , Recién Nacido , Embarazo , ADN Viral , Virus de la Hepatitis B , Hepatitis B Crónica , Sangre , Transmisión Vertical de Enfermedad Infecciosa , Leucocitos Mononucleares , Virología , Complicaciones Infecciosas del Embarazo , Virología
11.
Chinese Journal of Hepatology ; (12): 565-568, 2006.
Artículo en Chino | WPRIM | ID: wpr-341300

RESUMEN

<p><b>OBJECTIVE</b>To investigate the relationship between hepatitis C virus (HCV) genotype, serum viral load and ALT levels, and the factors associated with the viral relapse after IFN treatment in patients with chronic hepatitis C.</p><p><b>METHODS</b>The HCV RNA levels were determined with Cobas Amplicor Monitor Test, version 2.0, and HCV genotypes were examined by means of PCR products of 5' NTR digested with restriction endonucleases. The patients with chronic hepatitis C were treated with PEG-IFN alpha -2a and Roferon-A for 24 weeks. Those with a viral response after 24 week treatment were followed for an additional 24 weeks. The association of clinical characteristics, such as sex, age, the way of the HCV infection, IFN treatment history and platelet counts, and the HCV genotype, virus load and medicine used for the viral relapse after IFN treatment were analyzed.</p><p><b>RESULTS</b>Of the 208 chronic hepatitis C patients, the ALT levels were not related to HCV RNA levels (r = 0.093, P > 0.05). No difference of ALT levels between HCV genotypes was found, and the HCV RNA load was also of no difference between HCV genotype 1 patients and non 1 patients. Of the 119 patients with viral response after 24 week treatment, 58 cases (48.7%) relapsed after another 24 week's follow-up. Relapse was not significantly related to the clinical characteristics, such as sex, age, mode of the infection, treatment history of IFN, AST/ALT ratio, platelet counts and the baseline viral load. Among patients with genotype 1 virus, the relapse rate was significantly higher than those patients with non-genotype 1 virus (54.5% vs 32.1%, P=0.039). The relapse rate after PEG-IFN alpha -2a treatment was lower than that of Roferon-A treatment (47.0% vs. 52.8%), but not significantly.</p><p><b>CONCLUSION</b>The viral relapse of chronic hepatitis C patients after IFN treatment was significantly associated with the genotypes of the HCV.</p>


Asunto(s)
Femenino , Humanos , Masculino , Persona de Mediana Edad , Antivirales , Usos Terapéuticos , Genotipo , Hepacivirus , Genética , Hepatitis C Crónica , Quimioterapia , Virología , Interferón-alfa , Usos Terapéuticos , ARN Viral , Sangre , Proteínas Recombinantes , Recurrencia , Resultado del Tratamiento , Carga Viral
12.
Chinese Journal of Hepatology ; (12): 898-901, 2006.
Artículo en Chino | WPRIM | ID: wpr-285514

RESUMEN

<p><b>OBJECTIVE</b>To evaluate the efficacy and safety of a China made adefovir dipivoxil (ADV) treatment for hepatitis B e antigen-positive patients with chronic hepatitis B.</p><p><b>METHODS</b>Two hundred and thirty patients with chronic hepatitis B who were positive for hepatitis B e antigen (HBeAg) were randomly put into groups A or B, and 58 patients with lamivudine-resistant chronic hepatitis B were randomly put into groups C or D. During the first 12 weeks of the trial, 112 patients in group A and 115 patients in group B received 10 mg of ADV and a placebo once a day; 28 patients in group C received 100 mg of lamivudine (LMV) and 10 mg of ADV; 29 patients in group D received 100 mg of LMV and a placebo once a day. In the second trial period, all patients received ADV for 36 weeks. The primary checking criterion was the serum HBV DNA change during the treatment. The secondary ones were alanine aminotransferase (ALT) normalization, HBeAg loss, and HBeAg seroconversion.</p><p><b>RESULTS</b>At week 12, the median serum hepatitis B virus (HBV) DNA level of group A (ADV-ADV) was reduced 2.8 log10 copies/ml, significantly greater than that of group B (placebo-ADV) of 0.3 log10 copies/ml reduction (P = 0.000). At week 48, the median serum HBV DNA level of group A and group B were reduced 3.6 and 3.4 log10 copies/ml respectively. At week 12, the median serum HBV DNA level of group C (LMV+ADV) was reduced 3.0 log10 copies/ml, significantly greater than that of the group D (LMV+placebo) of 0.16 log10 copies/ml reduction (P = 0.000). At week 48, the median serum HBV DNA level of group C and group D were reduced 3.6 and 3.8 log10 copies/ml respectively. Only 5.56% (16/288) patients had adverse events that were mild to moderate. There was no significant difference in the change of serum creatinine compared with their baseline levels.</p><p><b>CONCLUSION</b>In our HBeAg positive lamivudine-resistant chronic hepatitis B patients, 48 weeks of ADV treatment was safe and resulted in significant virological and biochemical improvements.</p>


Asunto(s)
Adolescente , Adulto , Anciano , Humanos , Persona de Mediana Edad , Adulto Joven , Adenina , Usos Terapéuticos , Antivirales , Usos Terapéuticos , Método Doble Ciego , Farmacorresistencia Viral , Antígenos e de la Hepatitis B , Sangre , Hepatitis B Crónica , Quimioterapia , Alergia e Inmunología , Virología , Mutación , Organofosfonatos , Usos Terapéuticos
13.
Chinese Journal of Pediatrics ; (12): 855-858, 2006.
Artículo en Chino | WPRIM | ID: wpr-349514

RESUMEN

<p><b>OBJECTIVE</b>To study the mechanism and significance of peripheral blood mononuclear cell (PBMC) of neonates infected with hepatitis B virus (HBV).</p><p><b>METHODS</b>Eighty-four HBsAg-positive and HBeAg-negative mothers and their newborns were recruited in this study. Sixteen hepatitis B virus markers (HBVM)-negative mothers and their neonates were served as control. All these cases had no symptoms of hepatitis, serious pregnancy complications and preexisting disease. Age, gestational age and the method of delivery were matched in two groups (P > 0.05). Five ml blood samples were taken from the peripheral vein of the pregnant women before delivery and from neonates within 24 hours after birth, before inoculation of HBV vaccine (HBVac). Serum and PBMC were isolated from 2 ml and 3 ml samples respectively. The sera, PBMC and the last supernatant of PBMC washing were stored at -80 degrees C. HBVM of neonates were detected by using enzyme linked immunosorbent assay (ELISA). HBV DNA in serum, PBMC and the last supernatant of PBMC washing of mothers and neonates were detected by using a nested-polymerase chain reaction (n-PCR). Two pairs of oligonucleotide primers, the outer primer pair for first PCR and inner primer pair for second PCR, designed according to region S of HBV genome were synthesized at Shanghai Cell Biology Institute of Chinese Academy of Sciences. The neonates who were HBV DNA positive in PBMC but HBsAg and HBV DNA negative in serum were followed up for one year, HBsAb in serum and HBV DNA in PBMC were observed in the neonates.</p><p><b>RESULTS</b>(1) The positive rate of HBV DNA in 84 serum and PBMC of mothers were 53.57% and 40.48%, respectively (chi(2) = 2.891, P > 0.05). All the results were weakly positive. (2) Twenty-four (28.57%) newborns in the study group were infected, including 7 who were only HBV DNA positive in serum, 11 only HBV DNA positive in PBMC and 6 in both, all the results were weakly positive. HBsAg was negative in all the newborns. None of the neonates in control group was infected with HBV. There was significant difference between the two groups (chi(2) = 4.55, P < 0.05). (3) Of all the study cases, 11 (13.10%) neonates were HBV DNA weakly positive in PBMC but HBsAg and HBV DNA negative in serum. Of their mothers, 5 were only HBV DNA positive in serum, 2 only positive in PBMC and 4 positive in both serum and PBMC. Seven of the 11 neonates were followed up for one year and at the end of follow-up, 4 were HBsAb positive and HBV DNA negative in PBMC; 3 were HBsAb negative, and among the 3 cases HBV DNA in 2 was still positive in PBMC, HBsAg and HBV DNA in serum were negative in all the 7 neonates.</p><p><b>CONCLUSION</b>(1) HBV DNA positivity either in serum or in PBMC in mothers can result in infection of PBMC with HBV in their neonates. (2) PBMC infection with HBV can exist for a long time in neonates while HBsAg and HBV DNA are negative in serum, and may result in vaccination failure in neonates.</p>


Asunto(s)
Femenino , Humanos , Recién Nacido , Embarazo , Estudios de Casos y Controles , ADN Viral , Sangre , Hepatitis B , Diagnóstico , Alergia e Inmunología , Vacunas contra Hepatitis B , Virus de la Hepatitis B , Transmisión Vertical de Enfermedad Infecciosa , Leucocitos Mononucleares , Virología
14.
Journal of Southern Medical University ; (12): 193-195, 2006.
Artículo en Chino | WPRIM | ID: wpr-234163

RESUMEN

<p><b>OBJECTIVE</b>To investigate the expression of human annexin-V (HA-V) in relation to HBV infection in different fetal tissues.</p><p><b>METHODS</b>Immunohistochemistry was employed to detect the expression and distribution of HA-V in the liver, kidney, ovary, heart, fallopian tube, spleen, and thymus gland of human fetus.</p><p><b>RESULTS</b>HA-V expression was detected in different tissues including the ovary, liver, intrahepatic bile duct, heart, kidney, lymphocytic cells in the thymus gland, epithelial cells of the fallopian, and cortical and medullary cells of the spleen. HA-V was distributed mainly in the cytoplasm of the cells. The liver tissues exhibited greater gray scale for HA-V expression than in the other tissues (P<0.05) and no significant difference was observed in the other tissues than the liver (P>0.05) in image analysis with Photoshop 7.0.</p><p><b>CONCLUSION</b>HA-V is an inherent protein in fetal tissues with possible relation to HBV infection of different tissues as a HBV receptor. Greater amount of HA-V in the liver may account for the vulnerability of the liver to HBV infection.</p>


Asunto(s)
Humanos , Anexina A5 , Feto , Química , Virología , Hepatitis B , Metabolismo , Virología , Virus de la Hepatitis B , Inmunohistoquímica , Hígado , Química , Virología , Distribución Tisular
15.
Chinese Journal of Hepatology ; (12): 811-814, 2005.
Artículo en Chino | WPRIM | ID: wpr-276344

RESUMEN

<p><b>OBJECTIVE</b>To investigate the peripheral blood monocyte (PBMC) gene expression profile in a familial clustering of patients with chronic hepatitis B (CHB).</p><p><b>METHODS</b>cRNA prepared from PBMC in a family with 5 CHB patients and 4 normal controls was hybridized to high-density oligouncleotide arrays (HG-U133A 2.0 Human GeneChips, Affymetrix), which interrogate the expression of approximately 22,000 human ESTs. Primary image obtained from scanning was analysed with a DNT software package. Real-time PCR was employed to confirm the gene chip results.</p><p><b>RESULTS</b>55 genes out of 22,000 ESTs were identified differently. Among the 55 genes 14 showed increased expression and 41 showed decreased expression in the familial clustering CHB patients compared with those in normal controls. Most of the genes (57%) were involved in immunity, inflammation, apoptosis, signaling transduction, and cell cycle.</p><p><b>CONCLUSION</b>These results suggest that the hosts with this broad range of gene expression alterations are susceptible to hepatic B infection.</p>


Asunto(s)
Femenino , Humanos , Masculino , Análisis por Conglomerados , Salud de la Familia , Perfilación de la Expresión Génica , Predisposición Genética a la Enfermedad , Genética , Genoma , Hepatitis B Crónica , Genética , Leucocitos Mononucleares , Metabolismo , Análisis de Secuencia por Matrices de Oligonucleótidos , Linaje
16.
Biomedical and Environmental Sciences ; (12): 33-39, 2004.
Artículo en Inglés | WPRIM | ID: wpr-329657

RESUMEN

<p><b>OBJECTIVE</b>Elevation of reactive oxygen species (ROS), especially the level of superoxide is a key event in many forms of cardiovascular diseases. To study the mechanism of tea polyphenols against cardiovascular diseases, we observed the expressions of ROS-related enzymes in endothelial cells.</p><p><b>METHODS</b>Tea polyphenols were co-incubated with bovine carotid artery endothelial cells (BCAECs) in vitro and intracellular NADPH oxidase subunits p22phox and p67phox, SOD-1, and catalase protein were detected using Western blot method.</p><p><b>RESULTS</b>Tea polyphenols of 0.4 microg/mL and 4.0 microg/mL (from either green tea or black tea) down-regulated NADPH oxidase p22phox and p67phox expressions in a dose-negative manner (P < 0.05), and up-regulated the expressions of catalase (P < 0.05).</p><p><b>CONCLUSIONS</b>Tea polyphenols regulate the enzymes involved in ROS production and elimination in endothelial cells, and may be beneficial to the prevention of endothelial cell dysfunction and the development of cardiovascular diseases.</p>


Asunto(s)
Animales , Bovinos , Camellia sinensis , Química , Arterias Carótidas , Biología Celular , Catalasa , Células Cultivadas , Regulación hacia Abajo , Células Endoteliales , Metabolismo , Flavonoides , Farmacología , Proteínas de Transporte de Membrana , NADPH Deshidrogenasa , NADPH Oxidasas , Fenoles , Farmacología , Fosfoproteínas , Polifenoles , Especies Reactivas de Oxígeno , Metabolismo , Superóxido Dismutasa , Superóxido Dismutasa-1 , Regulación hacia Arriba
17.
Chinese Journal of Hepatology ; (12): 485-488, 2004.
Artículo en Chino | WPRIM | ID: wpr-250188

RESUMEN

<p><b>OBJECTIVE</b>To investigate the predictors of IFN therapy in patients with chronic hepatitis C through making the multivariate logistic regression analysis.</p><p><b>METHODS</b>The patients in the opened, randomized and controlled trial were enrolled into two group, pegasys and Roferon-A group, and were given 24 weeks of pegasys (injection of 180 microg a week), and Roferon-A (injection three times of Roferon-A 3 MU a week) therapy, and followed 24 weeks. The HCV RNA content was determined at the time before, end of treatment and at the followed-up. The association of the response to the treatment with the clinical characteristics including age, gender, way of HCV infection, history of IFN treatment, planet count, AST/ALT ratio, HCV RNA level, HCV genotype and treatment drugs was made trough multivariate logistic regression analysis.</p><p><b>RESULTS</b>The PP population containing 197 cases was analyzed. After controlling for age, gender, way of HCV infection, history of IFN treatment, planet count, AST/ALT ratio, HCV RNA level and treatment, the HCV genotype was not predictor of the end of treatment viral response (ETVR) to IFN therapy (OR 0.604, 95% CI 0.271-1.349, P = 0.219), but was the independent predictor of sustained viral response (SVR) (OR 0.408, 95% CI 0.189-0.881, P = 0.023). After controlling for other characteristics, the treatment drug was the predictors of ETVR (OR 0.105, 95% CI 0.052-0.212, P < 0.001) and SVR (OR 0.255, 95% CI 0.123-0.529, P < 0.001).</p><p><b>CONCLUSION</b>The pegasys using and HCV genotype were the independent predictors of the response to antiviral therapy in chronic hepatitis C.</p>


Asunto(s)
Adolescente , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Antivirales , Estudios de Seguimiento , Genotipo , Hepacivirus , Genética , Hepatitis C Crónica , Quimioterapia , Virología , Interferón-alfa , Modelos Logísticos , Polietilenglicoles , ARN Viral , Sangre , Proteínas Recombinantes
18.
Chinese Journal of Hepatology ; (12): 72-75, 2004.
Artículo en Chino | WPRIM | ID: wpr-240498

RESUMEN

<p><b>OBJECTIVE</b>To investigate the influence of HCV genotype on the IFN treatment of patients with chronic hepatitis C.</p><p><b>METHODS</b>The genotypes of HCV virus were determined in the patients enrolled into the Randomized, opened and controlled trial of Peg-IFN alpha-2a (Pegasys) treatment, controlled with IFN-alpha-2a (Roferon-A), on chronic hepatitis C patients in China. The serum ALT levels and HCV RNA concentration of the patients were detected in the time of before treatment, the end of therapy and follow-up. The influence of HCV genotype on the IFN treatment of patients with chronic hepatitis C was analyzed in intention to treat (ITT) population.</p><p><b>RESULTS</b>The HCV genotypes of 202 cases were determined. 158 (78.2%) cases infected with genotype 1 HCV and 44 (21.8%) cases with genotype non-1. For overall patients, the viral response at the end of treatment (ETVR) and sustained viral response (SVR) rates were 53.8% and 25.3% respectively in patients with genotype 1 HCV, but in genotype non-1 patients those was 61.4% and 43.2%, and the difference of SVR between genotype 1 and non-1 was significant (P=0.021). After grouped by the used drugs, in the patients given Pegasys treatment, the ETVR rates of patients with genotype 1 and non-1 HCV infection were 76.8% and 81.0%, the difference was not significant (P=0.686), but the difference of SVR rates, which were 35.4% and 66.7%, of the patients was significant (P=0.01). The viral relapse rate of genotype 1 was 55.6%; it was significant higher than that of genotype non-1 (23.5%) (P=0.02). In Roferon-A group, the ETVR and SVR rates of patients with genotype 1 HCV were 29.0% and 14.5%, which were lower, but not significant, than those of patients with genotype non-1 (43.5% and 21.7%). The viral relapse rate of genotype 1 was 72.7% and higher, but not significant, than that of genotype non-1 also (50.0%) (P=0.21).</p><p><b>CONCLUSION</b>HCV genotype could affects the efficacies, mainly the sustained responses, of IFN treatment of patients with chronic hepatitis C, and the effects of IFN were related to the kinds of drugs and therapeutic course.</p>


Asunto(s)
Humanos , Antivirales , Usos Terapéuticos , Genotipo , Hepacivirus , Clasificación , Genética , Hepatitis C Crónica , Quimioterapia , Virología , Interferón-alfa , Usos Terapéuticos , Polietilenglicoles , Usos Terapéuticos , Proteínas Recombinantes , Recurrencia
19.
Chinese Journal of Obstetrics and Gynecology ; (12)2001.
Artículo en Chino | WPRIM | ID: wpr-682981

RESUMEN

Objective To screen differentially expressed genes in placentas with hepatitis B virus (HBV)infection and to discuss the molecular mechanism of HBV intrauterine infection.Methods Thirty placenta tissue specimens from HBsAg and HBV DNA positive pregnant women were used as the study group and 30 placenta tissue specimens from normal pregnant women with HBsAg and HBV DNA negativity were served as the control group.The suppression subtractive hybridization(SSH)technique was used.Total RNAs of placenta tissue of the study group were mixed as the tester,and total RNAs of placenta tissue of the control group were mixed as the driver.A subtractive cDNA library was constructed by PCR-selective cDNA subtraction systems.Amplifications of the library were carried out with E.coil strain DH5? by reverse spot hybridization.RT-PCR confirmed that phosphatidylinositol 3-kinase(PI3K)was up-regulated in placenta tissue with HBV infection.Results Colony PCR showed that the clones contained 200-1000 bp inserts. Thirty five clones were confirmed by reverse spot hybridization and analyzed by sequencing and bioinformatics.Thirty three known genes and 2 genes with unknown function were obtained.RT-PCR preliminarily confirmed that PI3K gene was up-regulated in HBV infected placenta.Conclusions The differentially expressed genes in placentas with hepatitis B virus(HBV)infection using SSH technique has been screened out successfully.These differentially expressed genes encoding proteins participating in cell vital metabolism and malformation,and signal conduction-antiapoptosis pathway.This finding brings some new clues for studying the mechanisms of HBV intrauterine infection.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA